Somerville Kurt F Takes Position in SPDR S&P Biotech ETF $XBI

Somerville Kurt F acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 3,350 shares of the exchange traded fund’s stock, valued at approximately $294,000.

Other large investors have also added to or reduced their stakes in the company. Bank of America Corp DE boosted its position in SPDR S&P Biotech ETF by 13.3% during the 1st quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after buying an additional 1,700,851 shares during the period. Morgan Stanley raised its stake in shares of SPDR S&P Biotech ETF by 8.3% during the fourth quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock valued at $1,401,181,000 after acquiring an additional 882,718 shares during the last quarter. Wells Fargo & Company MN raised its stake in shares of SPDR S&P Biotech ETF by 75.7% during the fourth quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock valued at $434,835,000 after acquiring an additional 1,536,122 shares during the last quarter. Avoro Capital Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth $256,053,000. Finally, Bessemer Group Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 13.5% during the fourth quarter. Bessemer Group Inc. now owns 1,853,232 shares of the exchange traded fund’s stock worth $225,965,000 after purchasing an additional 220,244 shares during the period.

SPDR S&P Biotech ETF Trading Up 5.9%

NYSEARCA XBI opened at $169.55 on Thursday. The business’s 50-day moving average price is $152.74 and its two-hundred day moving average price is $137.22. SPDR S&P Biotech ETF has a 12 month low of $88.18 and a 12 month high of $169.68. The firm has a market capitalization of $11.07 billion, a PE ratio of 11.47 and a beta of 0.83.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.